Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 11 > >>
EC Number Crystallization (Commentary) Reference
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5- 209642, 209665, 209668
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5comparison of theoretically predicited model and experimentally elucidated structure 669910
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5crystal structure of tetrameric cytidine deaminase at 2.0 A resolution, hanging drop vapour-diffusion method 654638
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5hanging drop vapor diffusion method 712889
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5hanging drop vapour diffusion method. R56A and R56Q crystallize in the same space group as the wild-type enzyme with two subunits in the asymmetric unit, whereas C53H/R56Q can not crystallize in this crystal form but is crystallized in another space group, P3(2)21, with a full tetramer in the asymmetric unit 654757
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5in complex with inhibitor diazepinone riboside. Inhibitor is able to establish a canonical pi/pi interaction with key active site residue F137 669792
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5in complex with tetrahydrouridine, 3-deazauridine, or cytidine. Two alternate conformations of R68 influence zinc-product interaction 667736
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5purified CDA in complex with uridine and deoxyuridine, hanging drop vapor diffusion method, 0.002 ml of 12 mg/ml protein in 20 mM Tris-HCl pH 7.5 is mixed with 0.002 ml of reservoir solution containing 0.1 M HEPES, pH 7.5 and 4.3 M sodium chloride, ligands uridine and deoxyuridine are added by soaking method, X-ray diffractiuon structure determination and analysis at 2.4 and 1.9 A resolution,molecular dynamics simulation, structure modeling 718695
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5purified recombinant CDA complexed with either tetrahydrouridine, 3-deazauridine, or cytidine, hanging drop vapor diffusion technique, 25°C, protein solution, containing 10-15 mg/ml protein in 20 mM Tris-HCl, pH 7.5, 1 mM DTT, and 5 mM ligand, is mixed with crystallization solution containing 2.0 M ammonium sulfate and 0.1 M Tris-HCl, pH 8.5, crystals appear after a few hours or several days, respectively, X-ray diffraction structure determination and analysis at 1.48-2.36 A resolutions, molecular replacement 667736
Show all pathways known for 3.5.4.5Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.5structures of apomutants E47D and E47Q 755377
Results 1 - 10 of 11 > >>